Harvard 6th Annual Update in Neuro-Oncology 2026

July 22, 2026 – July 24, 2026

Deepen your expertise in neuro-oncology with this expert-led course offering the latest advances in diagnosis, treatment, and management of CNS and PNS tumors and neurological complications of cancer.

Neuro-oncology is a rapidly evolving multi-disciplinary field, which involves the medical, radiation, and surgical management of pediatric and adult patients with primary and metastatic tumors of the central nervous system (CNS) and peripheral nervous system (PNS).
This three-day course, the 6th Annual Update in Neuro-Oncology, is designed to provide an international audience with a comprehensive review of the diagnosis and management of pediatric and adult patients with primary and metastatic CNS and PNS tumors, specific neurogenetic syndromes, and neurological complications of cancer. In addition, modern molecular neuropathology and neuroradiology concepts essential for accurate diagnosis and classification will be covered.
The target audience consists of providers and trainees involved in the care of adult and pediatric neuro-oncology patients (neurologists, oncologists, radiation oncologists, neurosurgeons, neuroradiologists, and neuropathologists). The course will also be of high relevance to nurse practitioners, physician assistants, psychologists, pharmacists, nurses, and industry professionals.

Who Should Participate

Nurses, Pharmacists, Specialty Physicians, Nurse Practitioners, Physician Assistants, and Psychologists
Learning Objectives

Define the role of molecular biomarkers in the accurate diagnosis and classification of pediatric and adult CNS and PNS tumors.
Determine standard and novel treatment approaches to pediatric and adult CNS and PNS tumors.
Recognize and manage neurological complications associated with new cancer therapies.
Describe and manage long-term complications of CNS and PNS tumors and their treatment.

+ Topics:

Welcome Adult Neuro-Oncology

Advances in Surgery for Brain Tumors

Advances in the Imaging of Adult Brain Tumors

Advances in Radiation for Brain Tumors

WHO Classification for Adult Gliomas

Live Question and Answer Session Tracy Batchelor; E. Antonio Chiocca

Gliomas, IDH-Mutant

Gliomas, IDH-Wildtype

Advances in Experimental Therapies for Gliomas

Meningiomas

CNS lymphomas

Pituitary Tumors

Live Question and Answer Session L. Nicolas Gonzalez Castro; E. Antonio Chiocca

Live CNS Tumor Board L. Nicolas Gonzalez Castro

Welcome Neurological Complications of Cancer

Metastases to the Brain

Metastases to the Leptomeninges

Metastases to the Epidural Space and Spinal Cord

Paraneoplastic Neurological Syndromes

Live Question and Answer Session Patrick Wen; Tracy Batchelor

Common Neurological Complications in Cancer Patients

Neurological Complications of Cancer Immunotherapies

Survivorship of CNS tumors

Late Effects of Therapy in Pediatric CNS Tumor Survivors

Epilepsy and Brain Tumors Towards a Dual-activity Therapy

Live Question and Answer Session Patrick Wen

Live CNS Tumor Board Annie Hsieh

Opening Remarks Pediatric Neuro-Oncology Session

WHO Classification, Pediatric CNS Tumors

Advances in the Imaging of Pediatric Brain Tumors

Embryonal Tumors

Pediatric Low-Grade Gliomas

Pediatric High-Grade Gliomas

Ependymomas

Live Question and Answer Session Tracy Batchelor; Lissa Baird

Choroid Plexus Tumors

Pineal Tumors

Germ Cell Tumors

Neurofibromatosis and Schwannomatosis

Von Hippel Lindau

Live Question and Answer Session Lissa Baird; Tracy Batchelor

Live CNS Tumor Board Mariella Filbin; Ralph Salloum; Kee Kiat Yeo

Closing Statement